梁宏｜广西师范大学｜学者主页

2026

New Journal of Chemistry

DOI

2019

覃姣兰，曹倩倩，覃其品，梁宏，陈振锋

《中国科学:化学》

2017

RSC Advances

DOI

2014

Yan Peng, Minmin Zhang, Zhen‐Feng Chen, Kun Hu, Yan‐Cheng Liu, Xia Chen, Hong Liang

Bioinorganic Chemistry and Applications

DOI

2012

Di Yao, Jing Yu, Ying‐Ming Pan, Fu‐Ping Huang, He‐Dong Bian, Qing Yun Yu, Hong Liang

Chinese Journal of Chemistry

DOI

2011

Transition metal coordination compounds with oxoglaucine as ligand, synthesizing method thereof, and application thereof

Hong Liang, Zhen-Feng Chen, Yan-Cheng Liu, Yan Shi

Hong Liang

Guangxi kexue

2009

Binding Interaction of Xanthoxylin with Bovine Serum Albumin

Mao-Gui Wen, Xinbo Zhang, Jianniao Tian, Shouhai Ni, He‐Dong Bian, Yonglin Huang, Hong Liang

Journal of Solution Chemistry

DOI

2009

Synthesis, Cytotoxic Activity, and DNA Binding Properties of Copper (II) Complexes with Hesperetin, Naringenin, and Apigenin

Ming‐Xiong Tan, Jinchan Zhu, Ying‐Ming Pan, Zhen‐Feng Chen, Hong Liang, Huagang Liu, Heng‐Shan Wang

Bioinorganic Chemistry and Applications

DOI

2008

对-氢醌金属配合物:合成,结构及电化学性质(英文)

黄富平，王仪夏，赵婧，边贺东，于青，梁宏

《无机化学学报》

2008

吡啶-3-甲醛缩氨基硫脲合镍(Ⅱ)、锌(Ⅱ)配合物的合成、晶体结构及生物活性(英文)

边贺东，李春英，梁宇宁，郭桂全，于青，梁宏

《无机化学学报》

2008

天然药物有效成分的金属配合物研究进展

谭明雄，陈振锋，罗旭健，朱林，梁宏

《林产化学与工业》

2008

Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies

Zhen‐Feng Chen, Yan‐Cheng Liu, Limin Liu, Heng‐Shan Wang, San-Hai Qin, Bolong Wang, He‐Dong Bian, Bin Yang, Hoong‐Kun Fun, Huagang Liu, Hong Liang, Chris Orvig

Dalton Transactions

DOI

2007

链状螺旋配位聚合物[Zn（BBP）(p-CPOA)]n的合成及表征（英文）

杨燕，曾明华，张淑华，梁宏

《无机化学学报》

2007

之字链聚合物[Zn（o-bda）(phen)（H2O）]n·nH2O的结构（英文）

杨燕，曾明华，蒙法艳，邓前军，梁宏，张淑华

《无机化学学报》

2007

Hong Liang

Hecheng huaxue

2006

天然产物黄酮类化合物的提取、纯化及其金属配合物的研究进展

钟地长，张淑凤，陈振锋，王恒山，梁宏

《化学世界》

2006

牛血红蛋白与银纳米粒子相互作用的光谱研究

沈星灿，刘新艳，梁宏，卢昕

《化学学报》

2006

Applied Organometallic Chemistry

DOI

2004

刘冰，陈振锋，胡瑞祥，梁宏，郁开北

《无机化学学报》

2003

新型银胶基底研究HSA的近红外表面增强拉曼散射

沈星灿，郭俊怀，何锡文，梁宏，蒋治良

《化学学报》

2003

Hong Liang

2003

Crystallographic report: Crystal structure of the first alkaline earth metal compound with the antibacterial drug sulfasalazine: [Sr(H‐Sulf)(H 2 O) 6 ](H‐Sulf)·3H 2 O

Zhen‐Feng Chen, Shu Kang, Hong Liang, Feng Yi, Kai‐Bei Yu, Ren‐Gen Xiong, Xiao‐Zeng You

Applied Organometallic Chemistry

DOI

2002

Schiff碱N-氧化吡啶-2-甲醛缩氨基脲及其铜配合物的合成、晶体结构及谱学性质的研究

梁宏，陈雄斌，胡瑞祥，陈振锋，郁开北

《化学学报》

2002

蒋治良，冯志伟，刘庆业，蒋毅民，梁宏

《无机化学学报》

2001

Synthesis and crystal structure of heteronuclear La( III )‐Cu(II ) complex { [LaCu2(NTA)2(4,4′‐bpy)(H2O)3]NO3·5H2O}n

Fu‐Pei Liang, Zilu Chen, Rui‐Xiang Hu, Hong Liang, Man‐Bo Zhang, Kai‐Bei Yu

Chinese Journal of Chemistry

DOI

1999

4-(2-羟基苯基)-亚胺基-戊-2-酮的晶体结构和谱学性质研究

陈振锋，李舒婷，王修建，胡瑞祥，梁宏，郁开北

《有机化学》

1999

螺旋藻中药用成分的综合开发与应用

张文雄，梁宏，覃海错，黄文榜

《天然产物研究与开发》

1999

Cu(Ⅱ),Fe(Ⅲ)与人血清白蛋白相互作用的荧光光谱研究

梁宏，邢本刚，吴庆轩，罗济文，周永洽，申泮文

《化学学报》

1999

Mixed activation and mixed inhibition of the oxidoreductase activity of Rhus vernicifera laccase by different Pd2+ ion concentration

Chu‐Qiao Tu, Hong Liang, Guanghui Wang

Chinese Journal of Chemistry

DOI

1999

Chemistry of 2-mercaptophenol (H2mp) . Part iii. One dimensional arrays of binuclear anions of Mo (VI) linked by bis (2-hydroxyphenyl) disulfide via hydrogen bondings

Xiu‐Jian Wang, Zhen‐Feng Chen, Bei‐Sheng Kang, Hong Liang, Han-Qin Liu, Kai‐Bei Yu, Cheng‐Yong Su, Zhong‐Ning Chen

Polyhedron

DOI

1998

金属-血清蛋白的结构研究 Ⅲ.Ni2+离子诱导的HSA和BSA的缓慢构象变化（英文）

梁宏，欧阳砥，胡绪英，太俊哲，贺进田，周永洽

《化学学报》

1998

Equilibrium dialysis study on the interaction between Cu(II) and HSA or BSA

Hong Liang, Bengang Xin, Xiu‐Jian Wang, Yu-Zhou Yuan, Yongqia Zhou, Pan‐Wen Shen

Chinese Science Bulletin

DOI

1998

Structural Studies on Metal-Serum Albumin III . Slow Conformational Transition of HSA and BSA Induced by Ni~(2+) Ion

Hong Liang, Dongyan Ouyang, Xuning Hu, Jiajin Tai, Jiangling He, YQ Zhou

Acta Chimica Sinica

1997

[Application of UV spectroscopy in structural studies of metal centre of metal-protein].

Hong Liang, Yan Zhou, P Shen

PubMed

1992

金属—血清白蛋白的结构研究——Ⅵ.等离子点附近HSA和BSA中Cu(Ⅱ)和Ni(Ⅱ)金属中心的结构

周永洽，梁宏，郝韵琴，申泮文

《无机化学学报》

精选作品

期刊论文

8-羟基喹啉修饰的铂(Ⅱ)多吡啶配合物的合成及体内外抗癌活性评价

Stable Cyclometalated Gold(III) Complex Engaging Isoquinoline Derivative and Disulfur Ligand Elicits Necroptosis-Dependent Immunogenic Cell Death.

The Pt(IV) complexes of norcantharidin axial-modulated by carboxylic acid ligand: Synthesis, characterization, in vitro/in vivo anticancer efficacy and hypoxic activity

Oxoisoaporphine Half-Sandwich Osmium(II) Derivative: A Catalytic Trigger for Innate Tumor Chemoimmunotherapy

Near‐Infrared‐Responsive Black Calcium Carbonate With Oxygen Vacancies: Anchored Hydrogel Enhances Wound Healing via Photothermal Sterilization and Bio‐Activated Reaction

Sonosensitizer‐Functionalized Polymetallic Nanoenzymes for Photoacoustic Imaging‐Guided Cancer Sonodynamic Immunotherapy

GPX4-Targeting Phenolato Zr IV Complexes Induce Ferroptosis and Lysosome-Dependent Cell Death for Immunotherapy of Chemoresistant Cancer

Pt(IV) Complexes Incorporating CDC25A/NF-κB Dual Inhibitory 1,4-Naphthoquinone Derivatives Trigger Multimodal Cell Death in A2780 Ovarian Cancer Cells

Corrigendum to “Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands” [Eur. J. Med. Chem. 158 (2018) 442–452]

含吡啶侧链蒽腙-铜配合物的合成、晶体结构、抗肿瘤活性及DNA键合（英文）

Norcantharidin/Cu2+ dual-depleting GSH nanocatalyst with pH-responsive for CT/CDT synergistic cancer therapy

Copper(II) Complexes of Pyrazolopyrimidine Derivatives as Anticancer Agents with Enhanced Chemodynamic Therapy through Bimodal Apoptosis and Ferroptosis.

Oxoisoaporphine Alkaloid Iridium(III) Derivative: An Immunogenic Cell Death Inducer That Engages the Autophagy-Dependent Regulator Cathepsin D.

Isoquinoline-Derived Half-Sandwich Ru(II) Arene Complex Potentiates Antitumor Chemoimmunotherapeutic Response.

In vitro and in vivo studies on three new 8-hydroxyquinoline-based zinc(II) coordination compounds as potential antimelanoma cancer agents.

Recent advances in metal complexes and nanostructured materials for enhanced chemodynamic therapy

Zinc(II)–berberine-based complexes targeting mitochondria exhibit enhanced antiproliferative activity as single drugs or in combination with ABT-199

Oxoaporphine-Metformin Rhodium(III) Mixed Complex Achieving Dual Antidiabetes and Anticancer Effects by Interfering with Glucose Metabolism Reprogramming

Development of a theranostic tri-nuclear gadolinium(III) complex based on apoferritin for multitarget therapy of orthotopic glioma

Development of a High-Efficacy and Low-Toxicity Cobalt(II) Agent for Targeting Inhibition of Tumor Growth through Mitochondrial Damage-Mediated Chemotherapy and Immunotherapy

Bioorthogonal Reaction of β -Chloroacroleins with meta -Aminothiophenol to Develop Near-Infrared Fluorogenic Probes for Simultaneous Two-color Imaging

Synthesis and antitumor mechanisms of two new 8-hydroxyquinoline platinum( ii ) derivatives

Three novel dinuclear calcium( ii ) complexes with 5,7-dihalo-8-quinolinolato showing potent anticancer activity

Designing mitophagy-targeted robustine- and 4-acridinol-rhodium( iii ) coordination compounds to overcome cisplatin resistance in A549/DDP lung cancer cells

Dual-action arene‑osmium(II) oxoaporphine complex combats bladder cancer via microtubule disruption and PINK1/Parkin mitophagy induction

A Smart mRNA‐Initiated Theranostic Multi‐shRNA Nanofactory for Precise and Efficient Cancer Gene Therapy

Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple‐negative breast cancer

Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis

Cycloplatinated (II) Complex Based on Isoquinoline Alkaloid Elicits Ferritinophagy-Dependent Ferroptosis in Triple-Negative Breast Cancer Cells.

Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis

Rhodium(III) Complex Noncanonically Potentiates Antitumor Immune Responses by Inhibiting Wnt/β-Catenin Signaling.

Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin-Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment.

Discovery of mitochondrion-targeting copper(II)-plumbagin and -bipyridine complexes as chemodynamic therapy agents with enhanced antitumor activity.

Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium(III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune Response.

Sm(Ⅲ), Gd(Ⅲ), and Eu(Ⅲ) complexes with 8‐hydroxyquinoline derivatives as potential anticancer agents via inhibiting cell proliferation, blocking cell cycle, and inducing apoptosis in NCI‐H460 cells

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer

A universal gelation strategy of bivalent anions to construct nanofibrous lysozyme hydrogels for immunomemory anti‐recurrence of diabetic wound infection by activating the cGAS‐STING pathway

Self-Feedback DNAzyme Motor for Cascade-Amplified Imaging of mRNA in Live Cells and In Vivo

Rhenium(I) coordinated carbon nitride as type II immunogenic cell death inducers for enhancing photoimmunotherapy against triple-negative breast cancer

Size‐Switchable Ru Nanoaggregates for Enhancing Phototherapy: Hyaluronidase‐Triggered Disassembly to Alleviate Deep Tumor Hypoxia

A cofactor self-supplying and self-feedback DNAzyme nanodevice for cascade-amplified imaging of mRNA in living cells and in vivo

Acidity-responsive polyphenol-coordinated nanovaccines for improving tumor immunotherapy via bidirectional reshaping of the immunosuppressive microenvironment and controllable release of antigens

Recent advances in discrete Cu complexes for enhanced chemodynamic therapy

Marbofloxacin combined with heavy rare-earth ions makes better candidates for veterinary drugs: crystal structure and bio-activity studies

The lanthanide(III) complexes of new fluoropyrimidine hydrazone 8-quinolinol ligand: Synthesis, crystal structure and bioactive studies

Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer

Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer

Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response

Rational Design of a Hetero-multinuclear Gadolinium(III)–Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer

A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death

Insights into the antineoplastic activity and mechanisms of action of coumarin-coordinated 8-hydroxyquinoline ruthenium(II/III) compounds

Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistance

Copper(II) complexes with plumbagin and bipyridines target mitochondria for enhanced chemodynamic cancer therapy.

Oxoaporphine Pr(III) complex inhibits hepatocellular carcinoma progression and metastasis by disrupting tumor cell-macrophage crosstalk.

A Silver‐Induced Absorption Red‐Shifted Dual‐Targeted Nanodiagnosis‐Treatment Agent for NIR‐II Photoacoustic Imaging‐Guided Photothermal and ROS Simultaneously Enhanced Immune Checkpoint Blockade Antitumor Therapy

Visualization diagnosis of acute cerebral ischemia via sulfane sulfur-activated photoacoustic imaging

Synthesis and anticancer mechanisms of four novel platinum( ii ) 4′-substituted-2,2′:6′,2′′-terpyridine complexes

Near-Infrared-II-Activatable Self-Assembled Manganese Porphyrin-Gold Heterostructures for Photoacoustic Imaging-Guided Sonodynamic-Augmented Photothermal/Photodynamic Therapy

8-hydroxyquinoline-N-oxide copper(II)- and zinc(II)-phenanthroline and bipyridine coordination compounds: Design, synthesis, structures, and antitumor evaluation

Synthesis, crystal structure, DNA binding, and anticancer activity of the cobalt(II), nickel(II), and copper(II) complexes of 9-benzothiazolanthrahydrazone

Developing a Hetero-Trinuclear Erbium(III)–Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor

H2O2 Self-Supply and Glutathione Depletion Engineering Nanoassemblies for NIR-II Photoacoustic Imaging of Tumor Tissues and Photothermal-Enhanced Gas Starvation-Primed Chemodynamic Therapy

Platinum-Based Mcl-1 Inhibitor Targeting Mitochondria Achieves Enhanced Antitumor Activity as a Single Agent or in Combination with ABT-199

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin

In vitro and in vivo antitumor activities of Ru and Cu complexes with terpyridine derivatives as ligands

Glutathione-Activated In Situ Transformation of Nanosized Vanadium Oxides for Postoperative Precision Tumor Theranostics

Hydrogen Sulfide Gas Amplified ROS Cascade: FeS@GOx Hybrid Nanozyme Designed for Boosting Tumor Chemodynamic Immunotherapy

Platinum(II) 5-substituted-8-hydroxyquinoline coordination compounds induces mitophagy-mediated apoptosis in A549/DDP cancer cells

Gold Nanocluster Encapsulated Nanorod for Tumor Microenvironment Simultaneously Activated NIR‐II Photoacoustic/Photothermal Imaging and Cancer Therapy

In Situ Polymerization of Aniline Derivative in Vivo for NIR-II Phototheranostics of Tumor

Copper-Nitrogen-Coordinated Carbon Dots: Transformable Phototheranostics from Precise PTT/PDT to Post-Treatment Imaging-Guided PDT for Residual Tumor Cells

A mixed-valence biotinylated Cu( i / ii ) complex for tumor-targeted chemodynamic therapy accompanied by GSH depletion

A S -substituted Nile Blue-derived bifunctional near-infrared fluorescent probe for in vivo carboxylesterase imaging-guided photodynamic therapy of hepatocellular carcinoma

Copper( ii ) complex enhanced chemodynamic therapy through GSH depletion and autophagy flow blockade

Development of a zinc( ii ) 2-pyridinecarboxaldehyde thiosemicarbazone complex with remarkable antitumor and antiangiogenic activities

A Cu( i )-based Fenton-like agent inducing mitochondrial damage for photo-assisted enhanced chemodynamic therapy

Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor Microenvironment

In vitro and in vivo anticancer activity of novel Rh(III) and Pd(II) complexes with pyrazolopyrimidine derivatives